Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $215.31, with a market capitalization of 30.82B. The stock trades at a price-to-earnings (P/E) ratio of -131.18.
On 2026-06-07, Natera(NTRA) stock traded between a low of $214.82 and a high of $222.14. Shares are currently priced at $215.31, which is +0.2% above the low and -3.1% below the high.
Natera(NTRA) shares are trading with a volume of 848.84K, against a daily average of 1.44M.
In the last year, Natera(NTRA) shares hit a 52-week high of $256.36 and a 52-week low of $131.81.
In the last year, Natera(NTRA) shares hit a 52-week high of $256.36 and a 52-week low of $131.81.
NTRA News
...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Goldman Sachs analyst Evie Koslosky initiated coverage of Natera (NTRA) with a Neutral rating and $245 price target The firm views Natera as the current leader...
Analyst ratings
86%
of 21 ratingsMore NTRA News
New insider activity at Natera ( (NTRA) ) has taken place on June 3, 2026. Claim 55% Off TipRanks Unlock trusted, data-backed investing tools with TipRanks Prem...
Your personal portfolio doesn't necessarily need to mirror a billionaire investor's holdings. But let's face it -- they manage billion-dollar portfolios for a r...
Natera (NTRA) announced the appointments of Thomas Lynch, M.D., and Eric Rubin, M.D., to the Company’s board of directors. Unlock trusted, data-backed investin...
In late May 2026, the U.S. Supreme Court declined to hear the appeal in the long-running legal dispute between CareDx and Natera, effectively leaving the lower...
Wolfe Research analyst Paige Chamberlain assumed coverage of Natera (NTRA) with an Outperform rating and price target of $260, down from $275. As molecular resi...
The United States market has experienced a notable upswing, climbing 1.6% in the last week and rising 28% over the past year, with earnings expected to grow by...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.